Accuracy and Challenges in the Vesical Imaging‐Reporting and Data System for Staging Bladder Cancer
Background The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. Purpose To describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BC...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 56; no. 2; pp. 391 - 398 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.08.2022
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.
Purpose
To describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI‐RADS scoring system and the necessity of dynamic contrast‐enhanced (DCE) sequence.
Study Type
Retrospective.
Subjects
A total of 106 patients (include 16.5% female) with bladder cancer.
Sequence
T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).
Assessment
Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5‐point VI‐RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.
Statistical Tests
Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.
Results
Fourteen cases (13.2%) had discordant VI‐RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI‐RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.
Data conclusion
The DCE was crucial in the discordant group for evaluating muscle‐invasiveness, while DCE may not be necessary for the concordant group. The VI‐RADS scoring system performed with overall good diagnostic performance in evaluating muscle‐invasiveness in BCa patients.
Evidence Level
4
Technical Efficacy
Stage 3 |
---|---|
AbstractList | The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.BACKGROUNDThe Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.To describe the characteristics of cases with discordant T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI-RADS scoring system and the necessity of dynamic contrast-enhanced (DCE) sequence.PURPOSETo describe the characteristics of cases with discordant T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI-RADS scoring system and the necessity of dynamic contrast-enhanced (DCE) sequence.Retrospective.STUDY TYPERetrospective.A total of 106 patients (include 16.5% female) with bladder cancer.SUBJECTSA total of 106 patients (include 16.5% female) with bladder cancer.T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).SEQUENCET2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5-point VI-RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.ASSESSMENTSome cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5-point VI-RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.STATISTICAL TESTSReceiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.Fourteen cases (13.2%) had discordant VI-RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI-RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.RESULTSFourteen cases (13.2%) had discordant VI-RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI-RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.The DCE was crucial in the discordant group for evaluating muscle-invasiveness, while DCE may not be necessary for the concordant group. The VI-RADS scoring system performed with overall good diagnostic performance in evaluating muscle-invasiveness in BCa patients.DATA CONCLUSIONThe DCE was crucial in the discordant group for evaluating muscle-invasiveness, while DCE may not be necessary for the concordant group. The VI-RADS scoring system performed with overall good diagnostic performance in evaluating muscle-invasiveness in BCa patients.4 TECHNICAL EFFICACY: Stage 3.EVIDENCE LEVEL4 TECHNICAL EFFICACY: Stage 3. Background The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. Purpose To describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI‐RADS scoring system and the necessity of dynamic contrast‐enhanced (DCE) sequence. Study Type Retrospective. Subjects A total of 106 patients (include 16.5% female) with bladder cancer. Sequence T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo). Assessment Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5‐point VI‐RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards. Statistical Tests Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant. Results Fourteen cases (13.2%) had discordant VI‐RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI‐RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value. Data conclusion The DCE was crucial in the discordant group for evaluating muscle‐invasiveness, while DCE may not be necessary for the concordant group. The VI‐RADS scoring system performed with overall good diagnostic performance in evaluating muscle‐invasiveness in BCa patients. Evidence Level 4 Technical Efficacy Stage 3 The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. To describe the characteristics of cases with discordant T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI-RADS scoring system and the necessity of dynamic contrast-enhanced (DCE) sequence. Retrospective. A total of 106 patients (include 16.5% female) with bladder cancer. T2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo). Some cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5-point VI-RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards. Receiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant. Fourteen cases (13.2%) had discordant VI-RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI-RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value. The DCE was crucial in the discordant group for evaluating muscle-invasiveness, while DCE may not be necessary for the concordant group. The VI-RADS scoring system performed with overall good diagnostic performance in evaluating muscle-invasiveness in BCa patients. 4 TECHNICAL EFFICACY: Stage 3. BackgroundThe Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.PurposeTo describe the characteristics of cases with discordant T2‐weighted imaging (T2WI) and diffusion‐weighted imaging (DWI) scores in patients with BCa and further verify the accuracy of the VI‐RADS scoring system and the necessity of dynamic contrast‐enhanced (DCE) sequence.Study TypeRetrospective.SubjectsA total of 106 patients (include 16.5% female) with bladder cancer.SequenceT2WI (fast spin echo), DWI (echo planer imaging), and DCE (gradient echo).AssessmentSome cases are difficult to score according to the system, mainly when the T2WI (category 4) and DWI (category 2) sequence scores are discordant, termed the discordant group below. The complementary group will be termed concordant group. Each MRI sequence was reviewed respectively according to the 5‐point VI‐RADS scoring system by three observers. The diagnostic ability of sequences for evaluating muscle invasion by BCa was calculated using histopathology as the reference standards.Statistical TestsReceiver operating characteristic (ROC) curve, DeLong test, intraclass correlation coefficient. A P value of 0.05 or less was considered statistically significant.ResultsFourteen cases (13.2%) had discordant VI‐RADS scoring system. In the discordant group, the area under the ROC curve (AUC) of DCE was 0.875, while the T2WI and DWI showed limited diagnostic performance (AUCs = 0.50). In the concordant group, there was no significant difference in diagnostic efficacy between the overall VI‐RADS (AUC: 0.950) and the combination of T2WI and DWI (AUC: 0.946) (P = 0.56). Among all patients, the AUC of overall VIRADS was 0.939 with a 3 or greater cutoff value.Data conclusionThe DCE was crucial in the discordant group for evaluating muscle‐invasiveness, while DCE may not be necessary for the concordant group. The VI‐RADS scoring system performed with overall good diagnostic performance in evaluating muscle‐invasiveness in BCa patients.Evidence Level4Technical EfficacyStage 3 |
Author | Feng, Cui Li, Zhen Wang, Yanchun Hu, Henglong Meng, Xiaoyan Liu, Zheng Kamel, Ihab R. Hu, Daoyu |
Author_xml | – sequence: 1 givenname: Xiaoyan orcidid: 0000-0002-3424-6928 surname: Meng fullname: Meng, Xiaoyan organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 2 givenname: Henglong surname: Hu fullname: Hu, Henglong organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 3 givenname: Yanchun surname: Wang fullname: Wang, Yanchun organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 4 givenname: Cui orcidid: 0000-0001-9719-8436 surname: Feng fullname: Feng, Cui organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 5 givenname: Daoyu surname: Hu fullname: Hu, Daoyu organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 6 givenname: Zheng surname: Liu fullname: Liu, Zheng organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology – sequence: 7 givenname: Ihab R. orcidid: 0000-0003-0511-7796 surname: Kamel fullname: Kamel, Ihab R. organization: the Johns Hopkins Medical Institutions – sequence: 8 givenname: Zhen orcidid: 0000-0001-8037-4245 surname: Li fullname: Li, Zhen email: zhenli@hust.edu.cn organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35049074$$D View this record in MEDLINE/PubMed |
BookMark | eNp90ctu1DAUBmALFdELbHgAZIkNqpTixLdkWYYCg4qQWmAbnTjHU48cZ2o7QrPjEXhGnoR0prCoECufxfcfHfk_JgdhDEjI85KdlYxVr9dDdGdVzZR4RI5KWVVFJWt1MM9M8qKsmT4kxymtGWNNI-QTcsglEw3T4ojguTFTBLOlEHq6uAHvMawwURdovkH6DZMz4OlygJULq18_fl7hZox5nneJt5CBXm9TxoHaMdLrvHP0jYe-x0gXEAzGp-SxBZ_w2f17Qr6-u_iy-FBcfn6_XJxfFkZUXBScG9tIZlTPrJDAFLcN77DTyK1hiJ0A6JUCqxtpUVe2FqI3qkMFopZ9w0_Iq_3eTRxvJ0y5HVwy6D0EHKfUVqoqlWw01zN9-YCuxymG-bpZ1VpppWQ9qxf3auoG7NtNdAPEbfvnA2dwugcmjilFtH9Jydq7dtq7dtpdOzNmD7BxGbIbQ47g_L8j5T7y3Xnc_md5-_HT1XKf-Q2UBqJx |
CitedBy_id | crossref_primary_10_3390_cancers14133181 crossref_primary_10_1007_s00330_023_09960_y crossref_primary_10_1259_bjr_20230239 crossref_primary_10_1016_j_acra_2024_07_002 crossref_primary_10_1016_j_clgc_2022_03_002 crossref_primary_10_3390_diagnostics14040442 crossref_primary_10_1007_s00261_024_04245_4 crossref_primary_10_1007_s00261_024_04658_1 crossref_primary_10_1016_j_clinimag_2024_110279 |
Cites_doi | 10.1148/radiol.2019182506 10.1007/s00330-020-07153-5 10.1007/s00330-020-06802-z 10.2214/AJR.20.23604 10.1080/2090598X.2020.1733818 10.1002/jmri.27141 10.1016/j.ejrad.2020.109486 10.1016/j.eururo.2020.03.055 10.1016/j.eururo.2018.09.001 10.1007/s00330-019-06117-8 10.1016/j.eururo.2018.04.029 10.1016/j.eururo.2019.09.029 10.1259/bjr.20190401 10.1002/jmri.27361 10.1007/s00330-017-4758-3 10.1148/rg.287075154 10.1016/j.eururo.2019.08.016 10.1007/s00261-019-02190-1 10.21037/tau.2020.02.16 10.1007/s00261-018-1458-7 10.1002/jmri.26294 10.2214/AJR.20.22763 10.1148/radiol.2017171028 10.1016/j.euo.2020.02.007 10.1007/s00261-018-1614-0 10.1097/MD.0000000000002951 10.1007/s00330-020-07224-7 10.1016/j.eururo.2019.03.012 10.1007/s00330-020-07473-6 10.2463/mrms.2013-0104 10.3390/cancers12102994 |
ContentType | Journal Article |
Copyright | 2022 International Society for Magnetic Resonance in Medicine. 2022 International Society for Magnetic Resonance in Medicine |
Copyright_xml | – notice: 2022 International Society for Magnetic Resonance in Medicine. – notice: 2022 International Society for Magnetic Resonance in Medicine |
DBID | AAYXX CITATION NPM 7QO 7TK 8FD FR3 K9. P64 7X8 |
DOI | 10.1002/jmri.28064 |
DatabaseName | CrossRef PubMed Biotechnology Research Abstracts Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology Research Abstracts Technology Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-2586 |
EndPage | 398 |
ExternalDocumentID | 35049074 10_1002_jmri_28064 JMRI28064 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: National Natural Science Foundation of China funderid: 82102025; 82071889; 81771801 – fundername: National Natural Science Foundation of China grantid: 81771801 – fundername: National Natural Science Foundation of China grantid: 82102025 – fundername: National Natural Science Foundation of China grantid: 82071889 |
GroupedDBID | --- -DZ .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HDBZQ HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V8K V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7QO 7TK 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 K9. P64 7X8 |
ID | FETCH-LOGICAL-c4234-33cf950c6d0f45a063f93beb7e3fc0eeb4aad66af795fe72f844dc6be6a485d93 |
IEDL.DBID | DR2 |
ISSN | 1053-1807 1522-2586 |
IngestDate | Thu Jul 10 19:29:03 EDT 2025 Fri Jul 25 12:20:01 EDT 2025 Wed Feb 19 02:26:57 EST 2025 Tue Jul 01 03:56:52 EDT 2025 Thu Apr 24 23:12:45 EDT 2025 Wed Jan 22 16:23:41 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | multiparametric MRI Vesical Imaging-Reporting Data System diffusion-weighted imaging staging bladder cancer |
Language | English |
License | 2022 International Society for Magnetic Resonance in Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4234-33cf950c6d0f45a063f93beb7e3fc0eeb4aad66af795fe72f844dc6be6a485d93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-3424-6928 0000-0001-8037-4245 0000-0001-9719-8436 0000-0003-0511-7796 |
PMID | 35049074 |
PQID | 2687676658 |
PQPubID | 1006400 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2621659737 proquest_journals_2687676658 pubmed_primary_35049074 crossref_primary_10_1002_jmri_28064 crossref_citationtrail_10_1002_jmri_28064 wiley_primary_10_1002_jmri_28064_JMRI28064 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2022 |
PublicationDateYYYYMMDD | 2022-08-01 |
PublicationDate_xml | – month: 08 year: 2022 text: August 2022 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Nashville |
PublicationSubtitle | JMRI |
PublicationTitle | Journal of magnetic resonance imaging |
PublicationTitleAlternate | J Magn Reson Imaging |
PublicationYear | 2022 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2018; 286 2019; 92 2019; 291 2019; 76 2017; 27 2016; 95 2020; 12 2020; 77 2020; 55 2018; 43 2018; 48 2020; 18 2021; 79 2021; 31 2020; 3 2020; 31 2020; 30 2020; 52 2021; 136 2021; 216 2020; 9 2008; 28 2020; 214 2019; 29 2014; 13 2018; 74 2020; 45 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_12_1 e_1_2_8_30_1 |
References_xml | – volume: 216 start-page: 1257 issue: 5 year: 2021 end-page: 1266 article-title: VI‐RADS: Multiinstitutional multireader diagnostic accuracy and interobserver agreement study publication-title: AJR Am J Roentgenol – volume: 77 start-page: 101 issue: 1 year: 2020 end-page: 109 article-title: Prospective assessment of Vesical Imaging Reporting and Data System (VI‐RADS) and its clinical impact on the management of high‐risk non‐muscle‐invasive bladder cancer patients candidate for repeated transurethral resection publication-title: Eur Urol – volume: 79 start-page: 82 issue: 1 year: 2021 end-page: 104 article-title: European Association of Urology guidelines on muscle‐invasive and metastatic bladder cancer: Summary of the 2020 guidelines publication-title: Eur Urol – volume: 31 start-page: 1656 year: 2020 end-page: 1666 article-title: Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging‐reporting and data system publication-title: Eur Radiol – volume: 92 issue: 1104 year: 2019 article-title: Multiparametric MRI in differentiation between muscle invasive and non‐muscle invasive urinary bladder cancer with Vesical Imaging Reporting and Data System (VI‐RADS) application publication-title: Br J Radiol – volume: 9 start-page: 445 issue: 2 year: 2020 end-page: 451 article-title: Evaluation of vesical imaging‐reporting and data system (VI‐RADS) scoring system in predicting muscle invasion of bladder cancer publication-title: Transl Androl Urol – volume: 12 start-page: 2994 issue: 10 year: 2020 article-title: Systematic review and meta‐analysis of vesical imaging‐reporting and data system (VI‐RADS) inter‐observer reliability: An added value for muscle invasive bladder cancer detection publication-title: Cancers (Basel) – volume: 214 start-page: 1259 issue: 6 year: 2020 end-page: 1268 article-title: Overview of VI‐RADS in bladder cancer publication-title: AJR Am J Roentgenol – volume: 3 start-page: 306 issue: 3 year: 2020 end-page: 315 article-title: Diagnostic performance of vesical imaging reporting and data system for the prediction of muscle‐invasive bladder cancer: A systematic review and meta‐analysis publication-title: Eur Urol Oncol – volume: 18 start-page: 67 issue: 2 year: 2020 end-page: 71 article-title: The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging‐Reporting and Data System): A systematic review publication-title: Arab J Urol – volume: 286 start-page: 502 issue: 2 year: 2018 end-page: 511 article-title: The diagnostic value of MR imaging in differentiating T staging of bladder cancer: A meta‐analysis publication-title: Radiology – volume: 28 start-page: 1983 issue: 7 year: 2008 end-page: 1998 article-title: 3.0‐T MR imaging of the abdomen: Comparison with 1.5 T publication-title: Radiographics – volume: 29 start-page: 5498 issue: 10 year: 2019 end-page: 5506 article-title: Multiparametric MRI of the bladder: Inter‐observer agreement and accuracy with the Vesical Imaging‐Reporting and Data System (VI‐RADS) at a single reference center publication-title: Eur Radiol – volume: 45 start-page: 491 issue: 2 year: 2020 end-page: 498 article-title: Validation of vesical imaging reporting and data system for assessing muscle invasion in bladder tumor publication-title: Abdom Radiol (NY) – volume: 13 start-page: 175 issue: 3 year: 2014 end-page: 181 article-title: Preoperative T staging of urinary bladder cancer: Efficacy of stalk detection and diagnostic performance of diffusion‐weighted imaging at 3T publication-title: Magn Reson Med Sci – volume: 48 start-page: 882 issue: 4 year: 2018 end-page: 896 article-title: Update on multiparametric MRI of urinary bladder cancer publication-title: J Magn Reson Imaging – volume: 31 start-page: 875 year: 2020 end-page: 883 article-title: Clinical utility of the Vesical Imaging‐Reporting and Data System for muscle‐invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2‐weighted acquisitions publication-title: Eur Radiol – volume: 52 start-page: 1249 issue: 4 year: 2020 end-page: 1256 article-title: Vesical imaging‐reporting and data system for multiparametric MRI to predict the presence of muscle invasion for bladder cancer publication-title: J Magn Reson Imaging – volume: 95 issue: 10 year: 2016 article-title: Nonmuscle‐invasive and muscle‐invasive urinary bladder cancer publication-title: Medicine – volume: 76 start-page: 54 issue: 1 year: 2019 end-page: 56 article-title: Diagnostic accuracy and interobserver agreement for the Vesical Imaging‐Reporting and Data System for muscle‐invasive bladder cancer: A multireader validation study publication-title: Eur Urol – volume: 74 start-page: 784 issue: 6 year: 2018 end-page: 795 article-title: Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018 publication-title: Eur Urol – volume: 74 start-page: 294 issue: 3 year: 2018 end-page: 306 article-title: Multiparametric magnetic resonance imaging for bladder cancer: Development of VI‐RADS (Vesical Imaging‐Reporting And Data System) publication-title: Eur Urol – volume: 30 start-page: 4606 issue: 8 year: 2020 end-page: 4614 article-title: Use of vesical imaging‐reporting and data system (VI‐RADS) for detecting the muscle invasion of bladder cancer: A diagnostic meta‐analysis publication-title: Eur Radiol – volume: 55 start-page: 23 year: 2020 end-page: 36 article-title: VI‐RADS for bladder cancer: Current applications and future developments publication-title: J Magn Reson Imaging – volume: 31 start-page: 3874 issue: 6 year: 2021 end-page: 3883 article-title: Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi‐reader VI‐RADS approach publication-title: Eur Radiol – volume: 291 start-page: 668 issue: 3 year: 2019 end-page: 674 article-title: Multiparametric MRI for bladder cancer: Validation of VI‐RADS for the detection of detrusor muscle invasion publication-title: Radiology – volume: 136 year: 2021 article-title: Application of bi‐planar reduced field‐of‐view DWI (rFOV DWI) in the assessment of muscle‐invasiveness of bladder cancer publication-title: Eur J Radiol – volume: 76 start-page: 639 issue: 5 year: 2019 end-page: 657 article-title: European Association of Urology guidelines on non‐muscle‐invasive bladder cancer (TaT1 and carcinoma in situ) ‐ 2019 update publication-title: Eur Urol – volume: 43 start-page: 2431 issue: 9 year: 2018 end-page: 2441 article-title: Diagnostic performance of diffusion‐weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: Utility of evaluating the morphology of the reactive tumor stalk publication-title: Abdom Radiol – volume: 27 start-page: 3759 issue: 9 year: 2017 end-page: 3766 article-title: An evaluation of morphological and functional multi‐parametric MRI sequences in classifying non‐muscle and muscle invasive bladder cancer publication-title: Eur Radiol – volume: 43 start-page: 3509 issue: 12 year: 2018 end-page: 3510 article-title: "Inchworm sign" in urinary bladder cancer publication-title: Abdom Radiol (NY) – ident: e_1_2_8_8_1 doi: 10.1148/radiol.2019182506 – ident: e_1_2_8_20_1 doi: 10.1007/s00330-020-07153-5 – ident: e_1_2_8_18_1 doi: 10.1007/s00330-020-06802-z – ident: e_1_2_8_14_1 doi: 10.2214/AJR.20.23604 – ident: e_1_2_8_13_1 doi: 10.1080/2090598X.2020.1733818 – ident: e_1_2_8_21_1 doi: 10.1002/jmri.27141 – ident: e_1_2_8_23_1 doi: 10.1016/j.ejrad.2020.109486 – ident: e_1_2_8_2_1 doi: 10.1016/j.eururo.2020.03.055 – ident: e_1_2_8_3_1 doi: 10.1016/j.eururo.2018.09.001 – ident: e_1_2_8_9_1 doi: 10.1007/s00330-019-06117-8 – ident: e_1_2_8_6_1 doi: 10.1016/j.eururo.2018.04.029 – ident: e_1_2_8_11_1 doi: 10.1016/j.eururo.2019.09.029 – ident: e_1_2_8_7_1 doi: 10.1259/bjr.20190401 – ident: e_1_2_8_15_1 doi: 10.1002/jmri.27361 – ident: e_1_2_8_29_1 doi: 10.1007/s00330-017-4758-3 – ident: e_1_2_8_30_1 doi: 10.1148/rg.287075154 – ident: e_1_2_8_4_1 doi: 10.1016/j.eururo.2019.08.016 – ident: e_1_2_8_22_1 doi: 10.1007/s00261-019-02190-1 – ident: e_1_2_8_16_1 doi: 10.21037/tau.2020.02.16 – ident: e_1_2_8_25_1 doi: 10.1007/s00261-018-1458-7 – ident: e_1_2_8_28_1 doi: 10.1002/jmri.26294 – ident: e_1_2_8_27_1 doi: 10.2214/AJR.20.22763 – ident: e_1_2_8_5_1 doi: 10.1148/radiol.2017171028 – ident: e_1_2_8_32_1 doi: 10.1016/j.euo.2020.02.007 – ident: e_1_2_8_24_1 doi: 10.1007/s00261-018-1614-0 – ident: e_1_2_8_31_1 doi: 10.1097/MD.0000000000002951 – ident: e_1_2_8_19_1 doi: 10.1007/s00330-020-07224-7 – ident: e_1_2_8_10_1 doi: 10.1016/j.eururo.2019.03.012 – ident: e_1_2_8_12_1 doi: 10.1007/s00330-020-07473-6 – ident: e_1_2_8_26_1 doi: 10.2463/mrms.2013-0104 – ident: e_1_2_8_17_1 doi: 10.3390/cancers12102994 |
SSID | ssj0009945 |
Score | 2.4382968 |
Snippet | Background
The Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.
Purpose
To... The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018. To describe the... BackgroundThe Vesical Imaging‐Reporting and Data System (VI‐RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.PurposeTo... The Vesical Imaging-Reporting and Data System (VI-RADS) scoring system has been widely used to stage bladder cancer (BCa) since 2018.BACKGROUNDThe Vesical... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 391 |
SubjectTerms | Bladder Bladder cancer Cancer Correlation coefficient Correlation coefficients Diagnostic systems diffusion‐weighted imaging Histopathology Invasiveness Magnetic resonance imaging Medical imaging multiparametric MRI Muscles Performance evaluation Sequences staging Statistical analysis Statistical tests Vesical Imaging‐Reporting Data System |
Title | Accuracy and Challenges in the Vesical Imaging‐Reporting and Data System for Staging Bladder Cancer |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.28064 https://www.ncbi.nlm.nih.gov/pubmed/35049074 https://www.proquest.com/docview/2687676658 https://www.proquest.com/docview/2621659737 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh6oXSmmhCxS5ai9FypL4GUu9wFIESNsDAsQFRbZjS7QQUHb30J74CfzG_pKOnceKtkJqL5GljB_xjO3PGfsbhD5ww01quYC9CYWHy32iiC4TIkiu4Z1kOtwdHn8Rh2fs-IJfLKBP3V2Yhh-i_-EWRkacr8MA12ayMycN_XpTXw2DXzCQgYbDWgERncy5o5SKEYoBP9Aky1PZc5OSnXnWx6vRHxDzMWKNS87BC3TZNbY5afJtOJuaof3xG4_j_37NMlpqsSjebYznJVpw1Qp6Nm697a-Q27V2Vmv7HeuqxKMu7MoEX1UYcCM-d1HF-Ogmhjr6ef_QwHlIxxz7eqpxQ4mOARtjALZBDu9dh-muxqNgcfVrdHbw-XR0mLRhGRIL2IsllFqveGpFmXrGNWAcr6hxRjrqbeqcAfWWQmgvFfdOEp8zVlphnNAs56Wiq2ixuq3cG4Qp4CtipXHKMwal6VJlJHPKpdpkQssB-tipp7AtZ3kInXFdNGzLpAj9VsR-G6D3vexdw9TxV6nNTstFO1onBRGwJkgBYGyA3vWvYZwF54mu3O0syJBMwO6LQqPWGuvoq6E8-E8lFL4ddfxE_cXx-OQoptb_RXgDPSfh3kU8ebiJFqf1zL0FNDQ1W9HqfwG-Awak |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1PTxQxFG8QEvWi4t8F1Bq9aDLLTP9Oj7hAdoHlQMBwm7SdNkFhMLO7Bz3xEfiMfBJeO7OzQY2JXiZN5rWd6etrf-1rfw-hD9xwk1ouYG1C4eFynyiiy4QIkmt4J5kOd4fHh2J4wvZO-Wl7NifchWn4IboNt2AZcbwOBh42pDcXrKFfL-qzfnAMsntoJYT0jiuqowV7lFIxRjEgCJpkeSo7dlKyuch7dz76DWTexaxx0tl93ERWnUSuwnDW5Ft_NjV9-_MXJsf__p8n6FELR_FW039W0ZKrnqL749bh_gy5LWtntbY_sK5KPJhHXpngswoDdMRfXNQyHl3EaEc3V9cNood0zLGtpxo3rOgY4DEGbBvk8OfzMOLVeBA6Xf0cnezuHA-GSRuZIbEAv1hCqfWKp1aUqWdcA8zxihpnpKPeps4Z0HAphPZSce8k8TljpRXGCc1yXir6Ai1Xl5V7hTAFiEWsNE55xqA0XaqMZE65VJtMaNlDH-f6KWxLWx6iZ5wXDeEyKUK7FbHdeuh9J_u9Iev4o9TGXM1Fa7CTggiYFqQAPNZD77rXYGrBf6IrdzkLMiQTsACj8FEvm-7RVUN5cKFKKPxTVPJf6i_2xkejmFr7F-G36MHweHxQHIwO99fRQxKuYcSDiBtoeVrP3GsAR1PzJprALRYlCr8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSouUN4LBYzgAlK2iZ-xxKXssuoWtkIVRb2gyHZsqdCmVbp7gBM_ob-xv6Rj57EqICS4RJYyfsTjsT9n7G8QeskNN6nlAvYmFB4u94kiukyIILmGd5LpcHd4tiu299nOAT9YQW-6uzANP0T_wy1YRpyvg4Gfln5zSRr69bg-HAa_ILuGrjOR5mFMj_eW5FFKxRDFACBokuWp7MlJyeYy79Xl6DeMeRWyxjVncgt96VrbHDX5NlzMzdD--IXI8X8_Zx3dbMEo3mpGz2204qo7aG3WutvvIrdl7aLW9jvWVYlHXdyVM3xYYQCO-LOLOsbT4xjr6OLneYPnIR1zjPVc44YTHQM4xoBsgxx-exTmuxqPwpCr76H9ybtPo-2kjcuQWABfLKHUesVTK8rUM64B5HhFjTPSUW9T5wzotxRCe6m4d5L4nLHSCuOEZjkvFb2PVquTyj1EmALAIlYapzxjUJouVUYyp1yqTSa0HKBXnXoK25KWh9gZR0VDt0yK0G9F7LcBetHLnjZUHX-U2ui0XLTmelYQAYuCFIDGBuh5_xoMLXhPdOVOFkGGZAK2XxQa9aAZHX01lAcHqoTCX0cd_6X-Yme2N42pR_8i_AytfRxPig_T3feP0Q0S7mDEU4gbaHVeL9wTQEZz8zQawCURBAl3 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accuracy+and+Challenges+in+the+Vesical+Imaging%E2%80%90Reporting+and+Data+System+for+Staging+Bladder+Cancer&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Meng%2C+Xiaoyan&rft.au=Hu%2C+Henglong&rft.au=Wang%2C+Yanchun&rft.au=Feng%2C+Cui&rft.date=2022-08-01&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=56&rft.issue=2&rft.spage=391&rft.epage=398&rft_id=info:doi/10.1002%2Fjmri.28064&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jmri_28064 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon |